Nitric Oxide Synthase Activity and Renal Injury in Genetic Hypertension

Hypertension

Volumn 31, Issue 1, 1998, Pages 266-270

  Hayakawa, Hiroshi ^a   Raij, Leopoldo ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE SYNTHASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NOS3 PROTEIN, RAT;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; GLOMERULOPATHY; HYPERTENSION; INBRED STRAIN; INTERSTITIAL NEPHRITIS; KIDNEY DISEASE; KIDNEY INJURY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEINURIA; RAT; SALT INTAKE; SPONTANEOUSLY HYPERTENSIVE RAT; ABDOMINAL AORTA; ANIMAL; ENZYMOLOGY; GENETICS; GLOMERULUS; KIDNEY; KIDNEY CORTEX; KIDNEY MEDULLA; KIDNEY TUBULE; MALE; METABOLISM; PATHOLOGY; RAT STRAIN; VASCULAR SMOOTH MUSCLE; WISTAR KYOTO RAT;

ANIMALS; AORTA, ABDOMINAL; HYPERTENSION; KIDNEY; KIDNEY CORTEX; KIDNEY GLOMERULUS; KIDNEY MEDULLA; KIDNEY TUBULES; MALE; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; PROTEINURIA; RATS; RATS, INBRED SHR; RATS, INBRED STRAINS; RATS, INBRED WKY;

EID: 0031606271     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/01.HYP.31.1.266     Document Type: Article

References (31)

1. Hayakawa H, Raij L. The link among nitric oxide synthase activity, endothelial function, and aortic and ventricular hypertrophy in hypertension. Hypertension. 1997;29:235-241.
2. Raij L, Baylis C. Glomerular actions of nitric oxide. Kidney Int. 1995;48:20-32.
3. Derubertis FR, Craven PA. Activation of protein kinase C in glomerular cells in diabetes. Mechanisms and potential links to the pathogenesis of diabetic glomerulopathy. Diabetes. 1994:43:1-8.
4. Raij L, Luscher TF, Vanhoutte PM. High potassium diet augments endothelium-dependent relaxations m the Dahl rat. Hypertension. 1988;12:562-567.
5. Moncada S, Palmer RM, Higgs EA. The discovery of nitric oxide as the endogenous nitrovasodilator. Hypertension 1988:12:365-372.
6. Hayakawa H, Hirata Y, Suzuki E, Sugimoto T, Matsuoka H, Kikuchi K, Nagano T, Hirobe M, Sugimoto T. Mechanisms for altered eudothelium-dependent vasorelaxation in isolated kidneys from experimental hypertensive rats. Am J Physiol. 1993;264:H1535-H1541.
7. Navar LG, Majid DS. Interactions between arterial pressure and sodium excretion (Review). Curr Opin Neph Hypertens. 1996:S(1):64-71.
8. Mattson DL, Roman RJ, Cowley AW, Jr. Role of nitric oxide in renal papillary blood flow and sodium excretion. Hypertension. 1992;19:766-769.
9. Tolins JP, Palmer RMJ, Moncada S, Raij L. Role endothelium derived relaxing factor in the hemodynamic response to acetylcholine in vivo. Am J Physiol. 1989;258:H655-H662.
10. Fenoy FJ, Ferrer P, Carbonell L, Garcia-Salom M. Role of nitric oxide on papillary blood flow and pressure natriuresis. Hypertension. 1995;25:408-414.
11. Raij L, Azar S, Keane W. Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats. Kidney Int. 1984;26:137-143.
12. Panza JA, Garcia CE, Kilcoyne CM, Quyyumi AA, Cannon R Or. Impaired endothelium-dependent vasodilation in patients with essential hypertension. Evidence that nitric oxide abnormality is not localized to a single signal transduction pathway. Circulation. 1995;91:1732-1738.
13. Taddei S, Virdis A, Mattei P, Salvetti A. Vasodilation to acetylcholine in primary and secondary forms of human hypertension. Hypertension. 1993;21:929-933.
14. Hayakawa H, Hirata Y, Suzuki E, Kakoki M, Kikuchi K, Nagano T, Hirobe M, Omata M. Endothelium-derived relaxing factors in the kidney of spontaneously hypertensive rats. Life Sci. 1995;56:PL401-PL408.
15. Luscher TF, Vanhoutte PM. Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat. Hypertension. 1986;8:344-348.
16. Hirata Y, Hayakawa H, Kakoki M, Tojo A, Suzuki E, Kimura K, Goto A, Kikuchi K, Nagano T, Hirobe M, Omata M. Nitric oxide release from kidneys of hypertensive rats treated with imidapril. Hypertension. 1996;27:672-678.
17. Kato T, Iwama Y, Okumura K, Hashimoto H, Ito T, Satake T. Prostaglandin H2 may be the endothelium-derived contracting factor released by acetylcholine in the aorta of the rat. Hypertension. 1990;15:475-481.
18. Hayakawa H, Hirata Y, Suzuki E, Kimura K, Kikuchi K, Nagano T, Hirobe M, Omata M. Long-term administration of L-arginine improves nitric oxide release from kidney in deoxycorticosterone acetate-salt hypertensive rats. Hypertension. 1994;23:752-756.
19. Cowley AW, Roman RJ, Fenoy FJ, Mattson DL. Effect of renal medullary circulation on arterial pressure. J Hypertens. 1992;10(Suppl):S187-S193.
20. Majid DS, Godfrey M, Navar LG. Pressure natriuresis and renal medullary blood flow in dogs. Hypertension. 1997;29(4):1051-1057.
21. Fadem SZ, Hernandez-Llamas G, Patak RV, Rosenblatt SG, Lifschitz MD, Stein JH. Studies on the mechanism of sodium excretion during drug-induced vasodilation in the dog. J Clin Invest. 1982;69:604-610.
22. Ono H, Ono Y, Frohlich ED. Nitric oxide synthase inhibition in spontaneously hypertensive rats. Systemic, renal, and glomerular hemodynamics. Hypertension. 1995;26:249-255.
23. Fine LG, Norman JT, Ong A. Cell-cell cross-talk with the pathogenesis of renal interstitial fibrosis. (Review) Kidney Int. 1993;49(Suppl):S48-S50.
24. Muller GA, Markovic-Lipkovski J, Rodemann HP. The progression of renal diseases: on the pathogenesis of renal interstitial fibrosis. Klin Wochenschr. 1991;69:576-586.
25. Raij L, Azar S, Keane WF. Role of hypertension in progressive glomerular immune injury. Hypertension. 1985;7:398-404.
26. Ujiie K, Yuen J, Hogarth L, Danziger R, Star RA. Localization and regulation of endothelial NO synthase mRNA expression in rat kidney. Am J Physiol. 1994;267:F296-F302.
27. Terada Y, Tomita K, Nonoguchi H, Marumo F. Polymerase chain reaction localization of constitutive nitric oxide synthase and soluble guanylate cyclase messenger RNAs in microdissected rat nephron segments. J Clin Invest. 1992;90:659-665.
28. Cockcroft JR, Chowienczyk PJ, Benjamin N, Ritter JM. Preserved endothelium-dependent vasodilation in patients with essential hypertension. N Enql J Med. 1994;330:1036-1040.
29. Kannel WB. Blood pressure as a cardiovascular risk factor: prevention and treatment. JAMA. 1996;275:1571-1576.
30. Frohlich ED, Apstein C, Chobanian AV, Devereux RB, Dustan HP, Dzau V, Fauad-Tarazi F, Horan MJ, Marcus M, Massie B, Pfeffer MA, Re RN, Roccella EJ, Savage D, Shub C. The heart in hypertension. N Eng J Med. 1992;327:998-1008.
31. London G, Drueke T. Atherosclerosis and arteriosclerosis in chronic renal failure. Kidney lnt. 1997:51:1678-1695.